Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 (Rhizen Pharmaceuticals 3128)

Conditions:   Healthy Volunteers;   Asthma
Interventions:   Drug: RP3128;   Drug: Placebo
Sponsor:   Rhizen Pharmaceuticals SA
Recruiting – verified November 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *